{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T08:32:36Z","timestamp":1720686756710},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T00:00:00Z","timestamp":1519430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12033-018-0066-7","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T12:41:40Z","timestamp":1519476100000},"page":"251-258","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Interferon-\u03b1 Silencing by Small Interference RNA Increases Adenovirus Transduction and Transgene Expression in Huh7 Cells"],"prefix":"10.1007","volume":"60","author":[{"given":"Ana Alondra","family":"Sobrevilla-Navarro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Sandoval-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas Javier","family":"Garc\u00eda-Ba\u00f1uelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Armendariz-Borunda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Mar\u00eda","family":"Salazar-Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,24]]},"reference":[{"key":"66_CR1","unstructured":"https:\/\/www.wiley.com\/genmed\/clinical ."},{"issue":"Pt 1","key":"66_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.003087-0","volume":"90","author":"WC Russell","year":"2009","unstructured":"Russell, W. C. (2009). Adenoviruses: Update on structure and function. Journal of General Virology, 90(Pt 1), 1\u201320.","journal-title":"Journal of General Virology"},{"issue":"2","key":"66_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/156652306776359478","volume":"6","author":"DS Bangari","year":"2006","unstructured":"Bangari, D. S., & Mittal, S. K. (2006). Current strategies and future directions for eluding adenoviral vector immunity. Current Gene Therapy, 6(2), 215\u2013226.","journal-title":"Current Gene Therapy"},{"issue":"8","key":"66_CR4","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1128\/JVI.02685-06","volume":"81","author":"M Nociari","year":"2007","unstructured":"Nociari, M., et al. (2007). Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. Journal of Virology, 81(8), 4145\u20134157.","journal-title":"Journal of Virology"},{"issue":"7","key":"66_CR5","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1128\/JVI.02192-06","volume":"81","author":"J Zhu","year":"2007","unstructured":"Zhu, J., Huang, X., & Yang, Y. (2007). Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and-independent pathways. Journal of Virology, 81(7), 3170\u20133180.","journal-title":"Journal of Virology"},{"issue":"2","key":"66_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/sj.mt.6300031","volume":"15","author":"V Cerullo","year":"2007","unstructured":"Cerullo, V., et al. (2007). Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Molecular Therapy, 15(2), 378\u2013385.","journal-title":"Molecular Therapy"},{"issue":"4","key":"66_CR7","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1128\/JVI.01936-06","volume":"81","author":"ZC Hartman","year":"2007","unstructured":"Hartman, Z. C., et al. (2007). Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. Journal of Virology, 81(4), 1796\u20131812.","journal-title":"Journal of Virology"},{"issue":"7","key":"66_CR8","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/mt.2008.88","volume":"16","author":"J Zhu","year":"2008","unstructured":"Zhu, J., Huang, X., & Yang, Y. (2008). A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo. Molecular Therapy, 16(7), 1300\u20131307.","journal-title":"Molecular Therapy"},{"issue":"9","key":"66_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri1684","volume":"5","author":"T Decker","year":"2005","unstructured":"Decker, T., Muller, M., & Stockinger, S. (2005). The yin and yang of type I interferon activity in bacterial infection. Nature Reviews Immunology, 5(9), 675\u2013687.","journal-title":"Nature Reviews Immunology"},{"issue":"9","key":"66_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri888","volume":"2","author":"MG Katze","year":"2002","unstructured":"Katze, M. G., He, Y., & Gale, M., Jr. (2002). Viruses and interferon: A fight for supremacy. Nature Reviews Immunology, 2(9), 675\u2013687.","journal-title":"Nature Reviews Immunology"},{"issue":"3","key":"66_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/107999002753675695","volume":"22","author":"MG Katze","year":"2002","unstructured":"Katze, M. G. (2002). Interferon, PKR, virology, and genomics: what is past and what is next in the new millennium? Journal of Interferon and Cytokine Research, 22(3), 283\u2013286.","journal-title":"Journal of Interferon and Cytokine Research"},{"issue":"3","key":"66_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.18632\/oncotarget.231","volume":"2","author":"B Thaci","year":"2011","unstructured":"Thaci, B., et al. (2011). The challenge for gene therapy: innate immune response to adenoviruses. Oncotarget, 2(3), 113\u2013121.","journal-title":"Oncotarget"},{"issue":"5","key":"66_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jbiosc.2011.07.018","volume":"112","author":"J Armendariz-Borunda","year":"2011","unstructured":"Armendariz-Borunda, J., et al. (2011). Production of first generation adenoviral vectors for preclinical protocols: Amplification, purification and functional titration. Journal of Bioscience and Bioengineering, 112(5), 415\u2013421.","journal-title":"Journal of Bioscience and Bioengineering"},{"issue":"2","key":"66_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nprot.2006.83","volume":"1","author":"P Chomczynski","year":"2006","unstructured":"Chomczynski, P., & Sacchi, N. (2006). The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nature Protocols, 1(2), 581\u2013585.","journal-title":"Nature Protocols"},{"issue":"4","key":"66_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25(4), 402\u2013408.","journal-title":"Methods"},{"issue":"10","key":"66_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/jgm.1100","volume":"9","author":"ML Edelstein","year":"2007","unstructured":"Edelstein, M. L., Abedi, M. R., & Wixon, J. (2007). Gene therapy clinical trials worldwide to 2007\u2014an update. Journal of Gene Medicine, 9(10), 833\u2013842.","journal-title":"Journal of Gene Medicine"},{"issue":"3","key":"66_CR17","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.4049\/jimmunol.178.3.1767","volume":"178","author":"N Koizumi","year":"2007","unstructured":"Koizumi, N., et al. (2007). Fiber-modified adenovirus vectors decrease liver toxicity through reduced IL-6 production. Journal of Immunology, 178(3), 1767\u20131773.","journal-title":"Journal of Immunology"},{"issue":"12","key":"66_CR18","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1517\/17425247.2010.533655","volume":"7","author":"MB Mowa","year":"2010","unstructured":"Mowa, M. B., Crowther, C., & Arbuthnot, P. (2010). Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators. Expert opinion on drug delivery, 7(12), 1373\u20131385.","journal-title":"Expert opinion on drug delivery"},{"issue":"10","key":"66_CR19","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/JVI.70.10.6839-6846.1996","volume":"70","author":"VN Krasnykh","year":"1996","unstructured":"Krasnykh, V. N., et al. (1996). Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. Journal of Virology, 70(10), 6839\u20136846.","journal-title":"Journal of Virology"},{"issue":"3","key":"66_CR20","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/JVI.72.3.1844-1852.1998","volume":"72","author":"V Krasnykh","year":"1998","unstructured":"Krasnykh, V., et al. (1998). Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. Journal of Virology, 72(3), 1844\u20131852.","journal-title":"Journal of Virology"},{"issue":"2","key":"66_CR21","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/hep.21993","volume":"47","author":"Q Chen","year":"2008","unstructured":"Chen, Q., et al. (2008). Therapeutic RNA silencing of Cys-X3-Cys chemokine ligand 1 gene prevents mice from adenovirus vector-induced acute liver injury. Hepatology, 47(2), 648\u2013658.","journal-title":"Hepatology"},{"issue":"2","key":"66_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/sj.gt.3301647","volume":"9","author":"J Garcia-Banuelos","year":"2002","unstructured":"Garcia-Banuelos, J., et al. (2002). Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion. Gene Therapy, 9(2), 127\u2013134.","journal-title":"Gene Therapy"},{"issue":"4","key":"66_CR23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1053\/j.gastro.2003.12.045","volume":"126","author":"F Siller-Lopez","year":"2004","unstructured":"Siller-Lopez, F., et al. (2004). Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology, 126(4), 1122\u20131133. (discussion 949).","journal-title":"Gastroenterology"},{"issue":"6","key":"66_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1006\/mthe.2000.0210","volume":"2","author":"S Salgado","year":"2000","unstructured":"Salgado, S., et al. (2000). Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Molecular Therapy, 2(6), 545\u2013551.","journal-title":"Molecular Therapy"},{"issue":"21","key":"66_CR25","doi-asserted-by":"publisher","first-page":"15325","DOI":"10.1074\/jbc.R700002200","volume":"282","author":"J Hiscott","year":"2007","unstructured":"Hiscott, J. (2007). Triggering the innate antiviral response through IRF-3 activation. Journal of Biological Chemistry, 282(21), 15325\u201315329.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"66_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/107999099314360","volume":"19","author":"J Hiscott","year":"1999","unstructured":"Hiscott, J., et al. (1999). Triggering the interferon response: The role of IRF-3 transcription factor. Journal of Interferon and Cytokine Research, 19(1), 1\u201313.","journal-title":"Journal of Interferon and Cytokine Research"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12033-018-0066-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-018-0066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-018-0066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T17:38:31Z","timestamp":1603906711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12033-018-0066-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,24]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1007\/s12033-018-0066-7","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,24]]},"assertion":[{"value":"24 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors have nothing to disclose regarding conflicts of interest related to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}